Patents/Inventors

Peter J. Facchini

CalgaryCA31 patents

27 Patents

US126053612026
Carboxylated Psilocybin Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US125772322026
N-heterocycle Substituted Tryptamine Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US124921792025
Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives
Enveric Biosciences Canada Inc.
0 cites
US124284082025
Fused Heterocyclic Mescaline Derivatives
Enveric Biosciences Canada Inc.
0 cites
US123781952025
Aminated Psilocybin Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US123588852025
Substituted N-propylamine Fused Heterocyclic Mescaline Derivatives
Enveric Biosciences Canada Inc.
0 cites
US123382312025
N-heterocycle Substituted Tryptamine Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US121954392025
C1-substituted Isopropylamine Fused Heterocyclic Mescaline Derivatives
Enveric Biosciences Canada Inc.
0 cites
US121876792025
Hydroxylated Psilocybin Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US121382762024
Halogenated Psilocybin Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US121338562024
Multi-substituent Psilocybin Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US121280582024
Multi-substituent Psilocybin Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US120774982024
C4-carboxylic Acid-substituted Tryptamine Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US120654042024
C4-carboxylic Acid-substituted Tryptamine Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US119985572024
Halogenated Psilocybin Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US119457782024
C 4 -carbonothioate-substituted Tryptamine Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US119313382024
Nitrilated Psilocybin Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US119185942024
Multi-substituent Psilocybin Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US118913592024
Prenylated Psilocybin Derivatives and Methods of Using
ENVERIC BIOSCIENCES CANADA Inc.
0 cites
US118913602024
Glycosylated Psilocybin Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US118588952024
Aminated Psilocybin Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US118457262023
C 4 -carbonothioate-substituted Tryptamine Derivatives and Methods of Using
ENVERIC BIOSCIENCES CANADA Inc.
0 cites
US118457272023
Aldehyde and Ketone Derivatives of Psilocybin and Methods of Using
ENVERIC BIOSCIENCES CANADA Inc.
0 cites
US117521302023
Carboxylated Psilocybin Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US117460872023
C4-carboxylic Acid-substituted Tryptamine Derivatives and Methods of Using
ENVERIC BIOSCIENCES CANADA Inc.
0 cites
US117074472023
C4-carbonothioate-substituted Tryptamine Derivatives and Methods of Using
Enveric Biosciences Canada Inc.
0 cites
US115605782023
Neopinone Isomerase and Methods of Using
Antheia, Inc.
0 cites